⚠ AI-Generated

The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.

Zoetis maintained substantial continuity in its risk disclosure framework, with 43 risks remaining unchanged while four risks underwent substantive modifications. The modified risks centered on antibiotic restrictions in animal agriculture, product concentration dependency, customer financial pressures, and digital ordering platform management - reflecting evolving market dynamics without expanding or contracting the overall risk taxonomy. The absence of newly added or removed risk categories indicates Zoetis did not identify materially new risk areas or retire existing concerns between the two filing periods.

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

🟡 Modified Restrictions and bans on the use of and/or consumer preferences regarding antibacterials in food-producing animals may become more prevalent. 🔒

🟡 Modified Our results of operations are dependent upon the success of our top-selling products. 🔒

🟡 Modified Our business is subject to risk based on customer exposure to rising costs and reduced customer income. 🔒

🟡 Modified We may be unable to successfully manage our online ordering sites. 🔒

4 changes in this historical filing

Historical year-over-year comparisons (2025 vs 2024 and earlier) are available on the Pro plan.

Get full access — from $29/month Already a Pro subscriber? View full diff →